Identification of new treatments for epilepsy: issues in preclinical methodology

Preclinical research has facilitated the discovery of valuable drugs for the symptomatic treatment of epilepsy. Yet, despite these therapies, seizures are not adequately controlled in a third of all affected individuals, and comorbidities still impose a major burden on quality of life. The introduct...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Galanopoulou, Aristea S., Buckmaster, Paul S., Staley, Kevin J., Moshé, Solomon L., Perucca, Emilio, Engel, Jerome, Löscher, Wolfgang, Noebels, Jeffrey L., Pitkänen, Asla, Stables, James, White, Steve H., O’Brien, Terence J., Simonato, Michele
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3551973/
https://ncbi.nlm.nih.gov/pubmed/22292566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1528-1167.2011.03391.x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires